Background: The influence of dietary fat upon breast cancer mortality remains largely understudied despite extensive investigation into its influence upon breast cancer risk. Objective: To conduct meta-analyses of studies to clarify the association between dietary fat and breast cancer mortality. Design: MEDLINE and EMBASE were searched for relevant articles published up to March 2012. Risk of all-cause or breast-cancerspecific death was evaluated by combining multivariable adjusted estimates comparing highest versus lowest categories of intake; and per 20 g increase in intake of total and/or saturated fat (g/day) using random-effects meta-analyses. Results: Fifteen prospective cohort studies investigating total fat and/or saturated fat intake (g/day) and breast cancer mortality were included. There was no difference in risk of breast-cancer-specific death (n D 6; HR D 1.14; 95% CI: 0.86, 1.52; p D 0.34) or all-cause death (n D 4; HR D 1.73; 95% CI: 0.82, 3.66; p D 0.15) for women in the highest versus lowest category of total fat intake. Breast-cancer-specific death (n D 4; HR D 1.51; 95% CI: 1.09, 2.09; p < 0.01) was higher for women in the highest versus lowest category of saturated fat intake. Conclusions: These meta-analyses have shown that saturated fat intake negatively impacts upon breast cancer survival.
Introduction
As the number of breast cancer survivors increases worldwide (Cancer Research UK, 2011) , there is growing interest in the potential effect of dietary and lifestyle behaviors on overall prognosis. This is especially important as a cancer diagnosis is often referred to as a "teachable moment" when patients are motivated to make changes to their lifestyle and so provision of evidencebased guidelines is essential (Demark-Wahnefried et al., 2005) .
The widely postulated association between dietary fat and breast cancer risk was initially based upon ecologic and ani-mal studies (Willett, 1998; Greenwald, 1999; Hunter, 1999) . Subsequently, a randomized controlled trial (RCT) (Rohan et al., 2008) and multiple observational studies investigating the association have been conducted and several meta-analyses have reported increased breast cancer risk with increased dietary fat intake (Boyd et al., 1993; Boyd et al., 2003) . In a combined analysis of 12 case-control studies, saturated fat intake was also associated with an increased risk of breast cancer, especially in postmenopausal women (Howe et al., 1990 ). Yet in a pooled analysis of cohort studies, no evidence of any association was observed (Hunter et al., 1996) . The inconsistencies observed may be due to the studies included in the different meta-analyses, which span 13 years, or the methodologies used in these studies (Howe, 1994) . Consequently, the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) report on "Food, Nutrition, Physical Activity, and the Prevention of Cancer" (2007) concluded that there was limited suggestive evidence that total fat increases risk of postmenopausal breast cancer, but that for premenopausal breast cancer there was limited evidence and no conclusions could be drawn (WCRF/AICR, 2007) .
The influence of dietary fat on breast cancer mortality also remains unclear as the results of several RCTs are conflicting. In the Women's Intervention Nutrition Study (WINS), a reduction in breast cancer recurrence was seen in those who had adopted a low-fat dietary pattern (15% of energy intake from fat) with decreased intakes of oils and sweets and increased fruit consumption, in comparison with those in the control group. Yet there was significant weight loss in the intervention group and a higher frequency of mastectomy, which may have confounded results . In contrast, in the Women's Healthy Eating and Living (WHEL) randomized controlled trial, women in the intervention arm who consumed 15-20% of energy, 5 vegetable servings, 16 oz vegetable juice, 3 fruit servings and 30 g fiber per day did not have a significantly reduced risk of recurrence . Although the results obtained are of interest, it is impossible from these studies to firmly establish the effect of dietary fat intake on breast cancer mortality as they were designed to achieve an overall dietary intervention change, which only included a reduction in dietary fat intake.
In the absence of RCTs of fat and breast cancer recurrence, it is important to review other sources of evidence. A substantial number of cohort studies have examined the relationship between habitual dietary fat intake and breast cancer survival, yet, to date, the evidence provided by these has not been systematically reviewed. Our aim is to conduct a systematic review to establish whether an association exists between dietary fat intake and breast cancer mortality and, where possible, to quantify the relationship using meta-analysis of individual studies to produce a pooled estimate.
Methods

Study selection
An electronic literature search was conducted in the databases Ovid MEDLINE (US National Library of Medicine, Betheseda, MD) and EMBASE (Reed Elsevier PLC, Amsterdam, Netherlands) to identify human studies published in the English language up to March 2012 that included the following keywords or phrases: (dietary fat(s) or dietary cholesterol or saturated dietary fat(s)) and (survivorship or disease-free survival or survival rate or survival) and (breast neoplasm(s) or breast tumo (u)r or breast cancer survival or breast cancer or cancer of the breast). Four independent reviewers (SFB, PML, JVW, MMC) considered the abstracts of the articles retrieved in the initial search to identify potentially relevant studies that examined dietary fat and breast cancer mortality. All reviewers agreed on the potential articles and full-texts of these were obtained. Reference lists of the considered articles were searched for any further papers that may not have been identified in the database searches. Only studies that reported risk estimates (hazard ratios [HRs], odds ratios [ORs] , and relative risks [RRs]), and measures of variability (standard errors [SEs] or 95% confidence intervals [CIs] from which these could be derived), for all-cause and/or breast cancer mortality according to total fat intake and/or saturated fat intake were included.
Data extraction
Information extracted from each study included geographic region, study design, year of publication, sample size, number of cancer cases, dietary assessment method, timing of dietary assessment (relative to diagnosis), duration of follow-up, risk estimates with 95% CIs, and confounding variables adjusted for in the analysis.
Statistical analyses
The original studies reported HRs for all-cause or breast-cancer-specific death by categories (in fifths, fourths, or thirds) of total fat/saturated fat intake. Where possible, results were converted to g/day by calculation or by requesting the results in this format from the article author. Meta-analyses were conducted to evaluate the risk of all-cause or breast-cancer-specific death in women in the highest compared with the lowest reported categories of total fat intake (g/day) and women in the highest compared with the lowest categories of saturated fat (g/ day). Additionally, the linear increase in risk of breast cancer and all-cause death per percentile increase in total fat and saturated fat intake (g/day) was estimated by conducting a regression of the HRs in the categories of total and saturated fat intake against the average percentile in each category where possible using the methods by Greenland and Longnecker and otherwise using variance-weighted least-squares linear regression (Greenland and Longnecker, 1992) . This linear increase was converted to an estimate for a 20th percentile increase in total fat and/or saturated fat intake. Multivariable adjusted HRs, ORs, and RRs with 95% CIs from individual studies were weighted and combined using an inverse-variance weighted random-effects model to produce a pooled estimate (DerSimonian and Laird, 1986) . Heterogeneity was tested with a chisquared test and measured using the I 2 statistic (Higgins et al., 2003) . Each study's estimate and 95% CI and SE were presented in a forest plot along with the pooled estimate. Publication bias was assessed from inspection of the funnel plot and by statistical analysis using Begg's and Egger's tests (Sterne and Egger, 2001) .
Subgroup analyses were conducted for: studies that had adjusted for energy intake and for those that had not; studies that used FFQs for dietary assessment and those that used diet histories/recalls; and, finally, studies that assessed diet pre-diagnosis and those that assessed diet post-diagnosis Statistical analyses were conducted with Intercooled STATA version 9.2 (2005; StataCorp, College Station, TX).
Results
Inclusion
The electronic literature search identified 82 potentially relevant publications. Of these, 33 papers were initially excluded as they did not examine dietary fat and breast cancer mortality. Of the 49 articles that remained, the following papers were excluded: five RCTs (Winters et al., 2004; Chlebowski et al., 2006; Hoy et al., 2009; Stolley et al., 2009) , one ecological study (Kesteloot et al., 1994) , 18 reviews (Wynder et al., 1986; Chlebowski et al., 1992; Wynder et al., 1992; Cohen et al., 1993; Colditz, 1993; Ganz and Schag, 1993; Nixon, 1996; Stoll, 1996; Wynder et al., 1997; Jatoi and Loprinzi, 1999; Newman et al., 1999; Rock and Demark-Wahnefried, 2001; Blackburn et al., 2003; Holmes and Kroenke, 2004; Blackburn and Wang, 2007; Kellen et al., 2009 ), seven editorials/letters/supplements/communications (Hebert and Wynder, 1987; Lipmann, 1987; Thi ebaut et al., 2006; Gapstur and Khan, 2007; Kurt and Altundag, 2007; Nelson, 2008) , one study that examined marine fatty acid intake (Patterson et al., 2011) , one study that presented results as foods and not nutrients (Hebert et al., 1998) , and one study that did not provide usable estimates for dietary fat and breast cancer survival (Holm et al., 1993) .
Fifteen articles examined dietary fat intake (total fat and/or saturated fat (g)) and all-cause and breast cancer mortality and were included in the analyses (Gregorio et al., 1985; Newman et al., 1986; Nomura et al., 1991; Ewertz, 1993; Rohan et al., 1993; Jain et al., 1994; Zhang et al., 1995; Staessen et al., 1997; Holmes et al., 1999; Saxe et al., 1999; Goodwin et al., 2003; Borugian et al., 2004; McEligot et al., 2006; Holmes et al., 2009; Beasley et al., 2011) . Information extracted from each study included geographical region, sample size, age range, length of follow-up, dietary assessment method, timing of dietary assessment (relative to diagnosis), number of deaths, factors that were adjusted for in the analysis and risk estimates (HR, OR, RR), and factors that were adjusted for in the analysis (Table 1 ; Fig. 1 ).
Total fat intake
The association between highest compared with lowest categories of intake of total fat (g/day) and breast-cancer-specific and all-cause death are shown in Fig. 2A and 2B, respectively. There was no evidence of an association between total fat intake and risk of breast-cancer-specific death (n D 6; HR D 1.14; 95% CI: 0.86, 1.52; p D 0.34) or all-cause death (n D 4; HR D 1.73; 95% CI: 0.82, 3.66; p D 0.15) for women in the highest compared with the lowest categories of total fat intake. There was evidence of study heterogeneity in studies that examined the association between all-cause death and total fat intake (p < 0.01; I 2 D 84%). There was less evidence of heterogeneity between studies that examined breast-cancer-specific death and total fat intake (p D 0.115; I 2 D 44%).
Similarly, no significant difference in risk of all-cause (n D 3; HR D 1.06; 95% CI: 0.88, 1.28; p D 0.52) or breast-cancer-specific death (n D 4; HR D 1.03; 95% CI; 0.97, 1.10; p D 0.26) was observed per linear (20 g) increase in total fat intake. Once again, heterogeneity was most apparent in the analysis with studies providing estimates for all-cause death (p D 0.03; I 2 D 70%); no heterogeneity was evident for the studies providing estimates for breast-cancer-specific death (p D 0.44; I 2 D 0%).
Saturated fat intake
The association between highest compared with lowest categories of intake of saturated fat (g/day) and breast-cancer-specific death is shown in Fig. 3 . There was evidence of an increased risk of breast cancer death (n D 4; HR D 1.51; 95% CI: 1.09, 2.09) for the highest compared with the lowest category of intake of saturated fat (g/day) and these studies showed no evidence of heterogeneity (p D 0.317; I 2 D 15%). Only one study provided an estimate of risk for women in the highest compared to the lowest category of saturated fat intake and allcause death (HR D 2.4; 95% CI: 1.1, 4.9) (Zhang et al., 1995) .
No significant difference in risk of breast-cancer-specific death (n D 4; HR D 1.03; 95% CI: 0.77, 1.38; p D 0.80) was observed per linear (20 g) increase in saturated fat intake (results not shown). Heterogeneity was apparent in the analysis (p < 0.01; I 2 D 75%). Only one study provided an estimate of risk of all-cause death per linear (20 g) increase in saturated fat intake (HR D 1.01; 95% CI: 1.08, 1.88) (Zhang et al., 1995) .
Publication bias
Funnel plots revealed little evidence of asymmetry (not shown) and therefore little evidence of publication bias for studies examining the relationship between categories of total fat intake (g/day) and all-cause death (Begg's test: P D 0.355), and saturated fat intake (g/day) and breast-cancer-specific death (Begg's test: p D 0.156). There was some evidence of publication bias in the studies that reported an association between categories of total fat intake and breast cancer death (Begg's test: p D 0.05).
Sensitivity analyses
Sensitivity analyses were performed by removing studies that did not adjust for energy intake and by removing studies that used a dietary history/recall as opposed to a food frequency questionnaire, but no difference in the risk of all-cause or breast cancer death was observed for highest compared to the lowest intake of total fat (g/day) or saturated fat (g/day). Although not significant, slightly stronger associations were seen in studies investigating highest versus lowest intakes of total fat and breast-cancer-specific death that had adjusted for energy (n D 3; HR: 1.26; 95% CI: 0.84, 1.89) compared to those that did not (n D 3; HR: 1.10; 95% CI: 0.72, 1.68) and in studies that did not use FFQs (n D 2; HR: 1.59; 95% CI: 0.52, 4.91) compared to those that used FFQs to assess dietary intake (n D 4; HR: 1.08; 95% CI: 0.78, 1.48). Further sensitivity analyses involved examining the effect of the timing of dietary intake assessment. Again, the main results did not change markedly, but in studies that examined diet pre-diagnosis, highest versus lowest intakes of total fat intake were associated with an increased risk of allcause death (n D 3; HR: 2.65; 95% CI: 1.73, 4.05).
Discussion
To the best of our knowledge, this is the first systematic review and meta-analysis of observational studies examining dietary fat intake and breast cancer mortality. Results indicate that overall, a higher intake of saturated fat may increase the risk of breast cancer death. It has also shown that a higher total fat intake pre-diagnosis may increase the risk of all-cause death. In the absence of RCTs, which specifically test the efficacy of a low fat or low saturated fat diet in breast cancer survivors, this meta-analysis suggests that lower intakes of both total and saturated fat could be beneficial in terms of survival after a breast cancer diagnosis.
Although two RCTs, the WINS and the WHEL studies , have been conducted to examine the role of dietary fat on breast cancer prognosis to date, it is difficult to compare their results with the results of our meta-analysis. The investigators of these RCTs aimed to reduce the total fat intake of women in the intervention arm of the studies to 15-20% of energy intake. Women in the intervention arm of the WINS trial had a 24% reduction in risk of breast cancer death compared with the control group . However, women in the intervention arm also had significant weight loss, which could account for their lower risk of death, rather than the reduction in fat intake per se. Women in the intervention arm were also more likely to have had a mastectomy than in the control arm, which could also explain the difference in breast cancer survival between the study groups. Although the investigators of the WHEL trial reported no effect of their low fat intervention on breast cancer survival , it should be noted that women in the intervention arm also changed several other aspects of their diet to include 5 vegetable servings, 16 oz vegetable juice, 3 fruit servings, and 30 g fiber per day. Moreover, 75% of WHEL participants had healthy lifestyles and consumed at least five servings of fruit and vegetables per day at baseline and prior to randomization. The prevalence of healthy eating in the WHEL Studies included in analysis for highest versus lowest categories of total fat intake and breast-cancer-specific death.
2 Studies included in analysis for highest versus lowest categories of total fat intake and all-cause death. 3 Studies included in analysis of per 20 g increase in intake of total fat and breast-cancer-specific death. 4 Studies included in analysis of per 20 g increase in intake of total fat and all-cause death.
5
Studies included in analysis for highest versus lowest categories of saturated fat intake and breast-cancer-specific death. 6 Studies included in analysis of per 20 g increase in intake of saturated fat and breast-cancer-specific death. study is higher than other breast cancer survivor populations (Wayne et al., 2004; Caan et al., 2005) and it is possible that this intervention would have resulted in different outcomes in a population with less healthy lifestyles prior to the intervention.
There are a number of biologically plausible mechanisms whereby total or saturated fat intake may increase risk of breast cancer death. It has been hypothesized that fat intake promotes malignant mammary cell growth by increasing circulating estrogens (Wu et al., 1999; L€ of et al., 2007) . It has also been proposed that saturated fat intake may promote breast tumor growth by increasing low-density lipoprotein and cholesterol levels (Le Guevel and Pakdel, 2001) , by promoting an inflammatory response, and by reducing apoptosis as a result of altered gene expression (Willett, 1998; Lee et al., 2001) . As publications on dietary fat and breast cancer mortality and survival are few, our analyses were somewhat limited by the information available, and we were only able to examine total and saturated fat, but not monounsaturated, polyunsaturated, or trans-unsaturated fat intake and breast cancer survival, as these were not provided by the individual studies. It is likely, however, that these factors could also influence breast cancer survival, for example through formation of reactive oxygen species (Kang, 2002) .
Overall, total fat intake was not associated with breast-cancer-specific or all-cause death in the present study. However, women in the highest versus lowest category of total fat intake had an increased risk of all-cause death in studies that assessed diet pre-diagnosis. Although our results are limited by the information provided by the individual studies, they suggest the potential significance of the timing of dietary assessment around breast cancer diagnosis. As it has been widely reported that a cancer diagnosis motivates many cancer patients to adopt a lifestyle change (Demark-Wahnefried et al., 2005) , it would be of interest to further clarify the nature of this association. Furthermore, it is also possible that dietary intake during childhood and adolescence, which may influence a woman's future breast cancer risk, may also impact upon her prognosis (Moisan, 1990) . Therefore, it would also be of interest to further examine the association between dietary fat and mortality after breast cancer using more considered dietary assessment methods. In the present study, a higher versus lower intake of saturated fat was associated with an increased risk of breast cancer death, yet no linear relationships were observed. Similar results have been previously reported in a study by Goodwin et al. (2003) , where extremes of intake of polyunsaturated-saturated fat ratio, cholesterol, and percentage intake from fat, among other dietary components, were associated with breast cancer survival but linear associations were not observed. It is therefore possible that a mid-range intake of dietary fat, perhaps through consumption of a balanced diet, is most beneficial in terms of survival after a breast cancer diagnosis.
Of the 15 studies included in our analyses, 11 used a FFQ to assess dietary intake. The limitations of FFQs are well documented and include measurement error due to overestimation of the range of nutrient intakes and attenuation of risk estimates. Five studies included in our review used diet histories/ records, which are often considered more robust dietary assessment methods, to assess dietary fat intake. In our sensitivity analyses, we observed stronger associations when we removed studies that used FFQs (analyzing only those that used diet histories), although these results were not significantly different from the overall results. However, the results of the individual 0.2 0.5 2
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studies, regardless of whether they used an FFQ or a diet history, are limited by their use of one single measurement of diet, which cannot capture changes in dietary intake during the follow-up period and may not be representative of a woman's habitual diet. It has also been suggested that FFQs more accurately measure food intake rather than nutrient intake (Hebert et al., 1998) . Hebert et al. (1998) reported a positive association between intakes of butter, margarine, lard, red meat, and bacon and breast cancer recurrence. This finding supports the association shown between saturated fat and breast cancer death in our meta-analysis. There are inherent difficulties associated with combining results from individual studies, and the results of our metaanalysis are subject to the strengths and limitations of each study's design. The studies differed by geographical region, age range of participants, and time from diagnosis when the dietary assessment was made. Adjustment for confounders was also inconsistent between studies resulting in the potential for residual confounding; for example some studies did not adjust their analyses for total energy intake. However, we conducted sensitivity analyses excluding studies that did not report adjustment for energy intake and although the differences were not significant, we observed slightly stronger associations. Body Mass Index (BMI) or a change in weight after a breast cancer diagnosis, which has previously been shown to be associated with breast cancer prognosis (Protani et al., 2010; Conroy et al., 2011) , could not be controlled for in our analyses since adjustment across the individual studies was inconsistent. Additionally, it has been suggested that the influence of dietary fat on breast cancer risk and outcome may be dependent upon the hormone receptor status of the breast cancer Prentice et al., 2007) , but it was not possible to examine this as estimates were not provided by the original articles.
In conclusion, our results suggest that highest versus lowest intakes of saturated fat are associated with breast-cancer-specific death, while highest versus lowest intakes of total fat prediagnosis are associated with all-cause death. Modification of dietary intake, both prior to and at the time of diagnosis, to reduce total and saturated fat intake may therefore be warranted. Additional studies that assess dietary fat intake at the time of or after breast cancer diagnosis, rather than using prediagnostic measures as surrogates of post-diagnostic intake, are required to develop specific dietary recommendations for breast cancer survivors.
